Zobrazeno 1 - 9
of 9
pro vyhledávání: '"RM Bologa"'
Autor:
Kurt H. Stenzel, Thomas S. Parker, Daniel M. Levine, Albert L. Rubin, Bruce R. Gordon, Cheigh Js, A Lanto, RM Bologa
Publikováno v:
Clinical Nephrology. 72:437-441
Patients undergoing dialysis treatment have a high incidence of dyslipidemia. Rosuvastatin is a potent statin drug that improves overall lipid profiles in dyslipidemic patients. However, the pharmacokinetics of rosuvastatin has not been studied in pa
Autor:
Thomas S. Parker, Kurt H. Stenzel, David Serur, Daniel M. Levine, RM Bologa, Jhoong S. Cheigh, Albert L. Rubin
Publikováno v:
American Journal of Kidney Diseases. 32:107-114
Low serum albumin and low serum cholesterol levels are among the most consistent predictors of mortality in patients with end-stage renal disease (ESRD) undergoing hemodialysis. Hypoalbuminemia is often interpreted as a marker of poor nutrition, but
Autor:
Zhu F; Renal Research Institute, New York, New York, USA, fzhu@rriny.com., Abbas SR; Renal Research Institute, New York, New York, USA., Bologa RM; Rogosin Institute, New York, New York, USA., Levin NW; Renal Research Institute, New York, New York, USA., Kotanko P; Renal Research Institute, New York, New York, USA.; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Publikováno v:
Kidney & blood pressure research [Kidney Blood Press Res] 2019; Vol. 44 (6), pp. 1465-1475. Date of Electronic Publication: 2019 Nov 01.
Autor:
Sharma VK; Department of Transplantation Medicine & Extracorporeal Therapy, New York Hospital-Cornell Medical Center, New York, USA., Ding R, Li B, Bologa RM, Lagman M, Eduafo A, Edouard P, Mouradian J, Strom TB, Suthanthiran M
Publikováno v:
Transplantation proceedings [Transplant Proc] 1998 Aug; Vol. 30 (5), pp. 2364-6.
Autor:
Ding R; Department of Transplantation Medicine & Extracorporeal Therapy, New York Hospital-Cornell Medical Center, New York, USA., Li B, Sharma VK, Bologa RM, Lagman M, Mouradian J, Strom TB, Suthanthiran M
Publikováno v:
Transplantation proceedings [Transplant Proc] 1998 Aug; Vol. 30 (5), pp. 2370-2.
Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.
Autor:
Bologa RM; Rogosin Kidney Center and The New York Hospital, Cornell Medical College, New York 10021, USA. bologar@rockvax.rockefeller.edu, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 1998 Jul; Vol. 32 (1), pp. 107-14.
Autor:
Sharma VK; Rogosin Institute, Department of Transplantation Medicine & Extracorporeal Therapy, New York Hospital-Cornell Medical Center, NY 10021, USA., Bologa RM, Li B, Xu GP, Lagman M, Mouradian J, Wang J, Serur D, Rao VK, Suthanthiran M
Publikováno v:
Transplantation proceedings [Transplant Proc] 1997 Feb-Mar; Vol. 29 (1-2), pp. 1090-1.
Autor:
Sharma VK; The Rogosin Institute, Department of Transplantation Medicine, The New York Hospital-Cornell Medical Center, New York, NY 10021, USA., Bologa RM, Li B, Xu GP, Lagman M, Hiscock W, Mouradian J, Wang J, Serur D, Rao VK, Suthanthiran M
Publikováno v:
Transplantation [Transplantation] 1996 Dec 27; Vol. 62 (12), pp. 1860-6.
Autor:
Sharma VK; Rogosin Institute, Department of Transplantation Medicine and Extracorporeal Therapy, New York Hospital-Cornell Medical Center, New York, USA., Bologa RM, Xu GP, Li B, Mouradian J, Wang J, Serur D, Rao V, Suthanthiran M
Publikováno v:
Kidney international [Kidney Int] 1996 May; Vol. 49 (5), pp. 1297-303.